Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Kalytera Therapeutics Inc

(TSX-V: KALY.VN)
Add to Portfolio
unch (unch)
as of Apr 22, 2019

Last 0.050
Change unch (unch)
Open 0.050
Prev. Close 0.050
Today's Range
0.045
0.050
52wk Range
0.045
0.215
Volume 8,850,506
Avg Volume 5,411,841

Perfomance Comparison

Name Today 3-Month 1-Year
KALY.VN unch -37.50% -75.61%
$TXCX +0.84% +1.23% +13.79%
$TXCI +1.02% +1.09% +13.07%
DJIA +1.22% +4.18% +12.30%
S&P 500 +0.91% +5.65% +16.69%

Key Statistics

Annual EPS -0.210
Dividend Yield N/A
P/E Ratio N/A
Market Capitalization, $K 14,000
Weighted Alpha -81.26
Standard Deviation unch
Profit Margin N/A
Beta 3.254

Growth Rates

YTD -16.67%
1-Year -71.43%
3-Year -28.57%
5-Year +400.00%

Opinion

Sell Hold Buy

Recent Headlines

Kalytera Therapeutics Announces Filing of Short Form

GlobeNewswire via COMTEX - Wed Apr 17, 01:02PM EDT
/NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES/(full story)
KALY.VN: 0.050 (unch), KALTF: 0.0320 (-0.0010)

Kalytera Therapeutics Announces Short Form Prospectus

GlobeNewswire via COMTEX - Wed Apr 03, 08:25AM EDT
/NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES/(full story)
KALTF: 0.0320 (-0.0010), KALY.VN: 0.050 (unch)

Kalytera Reports Data for First Cohort in Phase 2

GlobeNewswire via COMTEX - Fri Mar 22, 07:29AM EDT
Kalytera Therapeutics, Inc. (TSX VENTURE: KALY and OTCQB: KALTF) (the "Company" or "Kalytera") today announced positive data from its ongoing Phase 2 clinical study evaluating cannabidiol ("CBD") for the prevention of acute graft (full story)
KALTF: 0.0320 (-0.0010), KALY.VN: 0.050 (unch)

Kalytera Announces Closing of Private Placement of

GlobeNewswire via COMTEX - Thu Mar 07, 06:54PM EST
/NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES/(full story)
KALTF: 0.0320 (-0.0010), KALY.VN: 0.050 (unch)

Kalytera Announces Initiation of Study KAL-07 - Food

GlobeNewswire via COMTEX - Wed Mar 06, 07:29AM EST
Kalytera Therapeutics, Inc. (TSX VENTURE: KALY and OTCQB: KALTF) (the "Company" or "Kalytera") today announced that it has initiated a food effect study ("Study KAL-07"), as part of its lead product development program evaluating (full story)
KALTF: 0.0320 (-0.0010), KALY.VN: 0.050 (unch)